Glucoraphanin for Health & Longevity

Created on 11/09/2026 – Quick Reference based on Evidence Review created using AI4L + evidence-mcp / Opus 5.5 – Audit

Glucoraphanin, a plant compound from broccoli sprouts and seeds sold as a dietary supplement, is used to switch on the body's antioxidant and detoxification defenses, which weaken with age. Human evidence is modest and partly commercially funded; the strongest finding is better memory and processing speed in older adults. Conversion to its active form varies widely. Side effects are mild and mostly digestive; raw sprouts carry infection risk. (Full Review)

Protocol

Standardized glucoraphanin capsules (Kagome)
30 mg once daily
About 69 µmol; used for 2 months in a liver trial and 42 months in a cognition trial
Myrosinase and chewing
Mustard seed myrosinase or thorough chewing of sprouts
Both increased conversion; an enzyme-free sprout drink yielded about 5% versus 70% for a sulforaphane-rich drink
Time of day
Morning or midday, with a meal
Conversion is greater during the day than at night; timing reflects common practice
Time to effect
Memory and processing speed
12 weeks to 30 months
Faster processing speed after 12 weeks; memory differences emerged only after 30 months
LDL cholesterol
12 weeks
Seen with high-glucoraphanin broccoli; evidence is indirect
Detoxification markers
7 days
Speculative benefit; excretion markers are unvalidated against cancer outcomes

Benefits

Contraindications
  • People with weakened immunity, pregnant women, young children and older adults (raw or lightly cooked sprouts only)
  • Pregnancy and breastfeeding (supplements)
  • Untreated hypothyroidism or iodine deficiency
  • Active cancer under treatment
  • Mustard allergy (products with mustard-seed myrosinase)
Key Interactions
  • CYP1A2 substrates (caffeine, theophylline, clozapine, tizanidine)
  • Proton pump inhibitors (omeprazole, esomeprazole)
  • Oral antibiotics and bowel cleansing (amoxicillin, bowel preparations)
  • Mustard seed powder (supplement, exogenous myrosinase)
  • Curcumin (supplement, another Nrf2 activator)
Theoretical (inferred from mechanism)
  • Levothyroxine and thyroid conditions
  • Warfarin
  • Glucose-lowering drugs (metformin, insulin, and sulfonylureas)
  • Chemotherapy agents (doxorubicin, cisplatin)
  • Other Nrf2-activating supplements (moringa, other broccoli products)

Risk & Side Effects

  • High:
  • Medium:
  • Low: Digestive Upset and Unpleasant Taste; Foodborne Infection from Raw Sprouts
  • Speculative: Thyroid Suppression; Support for Established Cancers; Blunted Training Adaptation

Monitoring

Marker Target Why
LDL cholesterol <100 mg/dL Expected to change: may fall modestly
ALT (alanine aminotransferase) About 7–55 U/L Safety check: liver
Fasting glucose 70–99 mg/dL Expected to change: may fall slightly
TSH About 0.4–4.0 mIU/L Safety check: thyroid, only in higher-risk groups

Cadence: Baseline before starting; lipid panel, ALT and glucose repeated at 12 weeks, then every 6–12 months; TSH rechecked at 8–12 weeks only in higher-risk groups

Qualitative Assessment

  • Digestive tolerance: absence of nausea, loose stools or reflux after the first week
  • Cognitive clarity: subjective sharpness and self-administered processing-speed or memory tests
  • Mood: fewer low or irritable days
  • Energy levels: daily energy and fatigue, tracked against baseline